Pharmacology, Toxicology and Pharmaceutical Science
Adenosine Triphosphate
8%
All Cause Mortality
6%
Anticoagulant Agent
33%
Anticoagulation Therapy
9%
Antivitamin K
42%
Apixaban
5%
Atrial Fibrillation
84%
Biological Marker
16%
Bleeding
20%
Brain Ischemia
5%
Cathepsin K
16%
Cerebrovascular Accident
20%
Cohort Study
36%
Concurrent Infection
16%
Dabigatran
22%
Drug Metabolism
16%
Drug Toxicity
8%
Gastric Inhibitory Polypeptide
16%
IC50
8%
Infection
16%
Liver Cell Carcinoma
8%
Long Untranslated RNA
16%
Retinol
7%
Thromboembolism
25%
Untranslated RNA
5%
Biochemistry, Genetics and Molecular Biology
Anticoagulation
13%
Atrial Fibrillation
33%
Cathepsin K
16%
CD14
6%
Cohort Study
18%
Dendritic Cell
6%
Drug Metabolism
5%
Dynamics
16%
Familial Atrial Fibrillation
8%
Gastric Inhibitory Polypeptide
16%
IC50
11%
Long Non-Coding RNA
16%
Membrane Protein
6%
Ossification
9%
Osteoblast
16%
Osteoclast
100%
Osteoclast Activity
25%
Osteoclastogenesis
8%
Osteolysis
63%
Precursor
19%
Single-Nucleotide Polymorphism
16%
Transmembrane Protein
6%
Tumor Spheroid
16%
Medicine and Dentistry
All Cause Mortality
5%
Anticoagulant Therapy
13%
Anticoagulation
35%
Antithrombotic
33%
Apixaban
5%
Apoplexy
20%
Atrial Fibrillation
50%
Biological Marker
6%
Bleeding
16%
Cathepsin K
10%
CHA2DS2-VASc Score
8%
Cohort Analysis
16%
Dabigatran
5%
Drug Metabolism
6%
Hazard Ratio
19%
IC50
5%
Infection
16%
Long Untranslated RNA
16%
Major Bleeding
5%
Osteoclast
33%
Osteoclastogenesis
7%
Osteolysis
19%
Retinol
7%
Thromboembolism
16%
Trypsinization
16%
Tumor Spheroid
16%
Vitamin K Antagonist
27%
